What Is a Non-Coring Needle and How Does It Work?

A non-coring needle is a specialized hollow needle whose tip is ground at an angle that lets it slip through a rubber or silicone membrane without punching out a tiny plug of material. Standard hypodermic needles have a sharp, beveled point that acts like a miniature hole punch, slicing a small core from whatever it pierces. The non-coring design avoids that by deflecting the cutting edge to one side, so the needle parts the membrane’s fibers rather than removing them. This distinction matters most in medicine when the membrane in question is the self-sealing septum of an implanted port, a device that may need to be accessed hundreds of times over months or years of treatment.

How the Tip Design Actually Works

Picture a standard needle tip under magnification. Its bevel creates a sharp, open-faced edge that scoops through tissue or silicone the same way a paper-hole punch cuts through a sheet. Each puncture carves out a tiny cylinder of material. Now picture a non-coring needle: the opening of the needle sits on the side of the shaft rather than at the very tip, and the point itself is a solid, deflected wedge. When this needle enters a silicone septum, the closed point pushes the material aside. The fluid pathway exits through that lateral opening rather than through the tip. The septum stretches open momentarily, and when the needle is withdrawn, the silicone springs back to its original shape, resealing itself.

This geometry is often called a Huber point, named after its actual inventor, a Seattle dentist named Ralph L. Huber. The needle was long misattributed to anesthesiologist Edward Tuohy, who popularized it in 1945 for use in continuous spinal anesthesia. Tuohy adapted Huber’s design for epidural work, and his name stuck to the needle in clinical parlance, but historical research has confirmed that Huber was the true originator of the deflected-point concept.¹ The introduction of this needle design made continuous epidural anesthesia for labor possible, a milestone in obstetric pain management.²

Why Coring Is a Problem

The entire reason non-coring needles exist comes down to what happens when a standard needle repeatedly pierces a silicone septum. Each puncture with a conventional beveled needle can shear off a microscopic fragment of silicone. Over dozens or hundreds of accesses, those fragments accumulate inside the port reservoir. In a documented case, a standard needle puncture produced a silicone core that migrated to the port’s outlet hole. During infusion, that core acted like a one-way valve: blood could still be drawn through the port, but fluid could not flow out. This kind of dysfunction is difficult to diagnose because the port appears to work in one direction, masking the blockage. The clinical team concluded that using standard needles instead of non-coring ones can reduce device effectiveness and expose patients to serious complications.³

Beyond mechanical occlusion, loose silicone fragments can theoretically travel into the bloodstream. The septum is designed to reseal itself thousands of times over a port’s lifespan, but only if punctured with the right tool. Every core taken from the septum also weakens the membrane slightly, eventually compromising the seal and making leaks more likely. For patients receiving chemotherapy drugs, which are often highly toxic to surrounding tissue if they leak, a compromised seal is not a minor inconvenience.

Where Non-Coring Needles Are Used

The primary home for these needles is the totally implantable venous access device, usually just called a port. A port is a small disc-shaped reservoir, typically titanium or plastic, surgically placed under the skin of the chest. A catheter runs from the port into a large central vein. Patients who need frequent or long-term intravenous therapy, especially chemotherapy, receive a port so their peripheral arm veins are not destroyed by repeated punctures or caustic drugs. Accessing that port means pushing a non-coring needle through the skin and into the silicone septum on top of the reservoir.

Cancer treatment is the most common scenario. An evidence summary focused on non-coring needle management in implantable ports for oncology patients emphasized that standardizing how these needles are used and maintained can minimize complications and improve treatment safety and quality of life.⁴ But ports are also used for long-term antibiotic therapy, total parenteral nutrition, and conditions requiring frequent blood draws or transfusions. In all of these settings, the non-coring needle is the standard access tool.

Choosing the Right Size

Non-coring needles come in a range of gauges and lengths, and picking the correct one for each patient matters more than you might expect. The gauge (the needle’s diameter) determines flow rate: a wider needle allows faster infusion but creates a larger puncture in the septum. For routine hydration or medication, a thinner gauge works fine. For blood product transfusions or high-volume fluid resuscitation, a larger bore is often needed. The length has to match the depth of the port beneath the skin, which varies depending on how much tissue sits between the skin surface and the port chamber. Patients with more subcutaneous tissue need a longer needle to reach the septum, while a shorter needle suits someone with a leaner build. Using a needle that is too short risks missing the septum entirely or not seating properly, which increases the chance of dislodgement and leakage. Using one that is too long can damage the septum by pressing the needle tip against the back wall of the reservoir.

Needle Orientation During Use

Once the needle is seated in the port, which direction it faces turns out to matter for something practical: how well the port flushes. Ports need to be flushed with saline (and sometimes heparin) after use to prevent clot formation in the reservoir and catheter. Experimental testing combined with computational modeling found that pointing the Huber needle’s opening in the direction diametrically opposite to the port’s exit channel increased flushing efficiency.⁵ In plain terms, when the saline stream hits the wall opposite the outlet before swirling toward the exit, it does a better job sweeping residual fluid and debris out of the chamber. This is a small detail that can make a real difference over time, since poor flushing is a leading cause of port occlusion.

Pain Management During Port Access

Having a non-coring needle pushed through your skin into a port is not painless. The needle is thicker than a standard blood-draw needle, and the push required to pierce the septum adds a distinctive “pop” sensation that many patients find unpleasant, especially after repeated treatments. A significant amount of research has gone into figuring out how to make the experience less painful.

A randomized controlled trial tested lidocaine spray applied before needle insertion and found that patients who received the spray reported pain scores averaging about 15 mm on a 100 mm visual scale, compared to roughly 37 mm in the control group. Moderate pain occurred in under 5% of the spray group versus over 40% of the control group, and severe pain appeared only in patients who received no spray at all.⁶ Another trial compared topical lidocaine cream (EMLA), the Valsalva maneuver (bearing down as if straining), and a combination of both. The cream alone and the combination provided the lowest pain scores, and both produced higher comfort levels than standard care.⁷

A network meta-analysis that pooled data from multiple randomized trials ranked the available interventions. Lidocaine cream combined with the Valsalva maneuver came out on top, followed by lidocaine spray, lidocaine cream alone, and the Valsalva maneuver alone. Cold spray, cryotherapy, and cutaneous stimulation therapy were less effective, and standard care with no intervention ranked last.⁸ The practical takeaway for patients: if your port access hurts, ask about topical anesthetic. It is a simple intervention that makes a measurable difference, and combining it with a brief bearing-down breath appears to help even more.

Infection Control Around Port Access

Every time a non-coring needle enters the skin, there is an opportunity for bacteria to hitch a ride into the bloodstream through the port. Catheter-related bloodstream infections are one of the most serious complications of any central venous device. European guidelines on parenteral nutrition and central venous catheter management identified a cluster of evidence-based practices that reduce this risk: proper hand hygiene, skin disinfection with chlorhexidine before insertion, use of maximal barrier precautions, routine changes of administration sets, appropriate dressing of the exit site, and removing the line as soon as it is no longer needed.⁹ For ports specifically, the needle itself should not stay in place indefinitely. Most institutional protocols call for replacing the non-coring needle every five to seven days during continuous use to reduce both infection risk and septum damage.

Training matters at least as much as equipment. The same guidelines emphasized that proper education and specific training of staff are among the most cost-effective interventions for preventing catheter infections.⁹ An experienced nurse who accesses a port cleanly and efficiently is doing more to prevent complications than any antimicrobial coating or fancy dressing. For patients learning to recognize signs of trouble, redness, swelling, warmth, or fever after port access are reasons to call the care team immediately.

The Non-Coring Concept in Spinal and Epidural Needles

The same principle that protects a port septum applies, with some variation, to spinal anesthesia. When a needle enters the dura mater (the tough membrane surrounding the spinal cord), it creates a hole. If that hole is large or ragged, cerebrospinal fluid can leak out, producing a post-dural-puncture headache that can be debilitating. Cutting-type spinal needles, which have a standard bevel, tend to slice the dural fibers and create a flap. Pencil-point needles, which have a closed, rounded tip similar in concept to the Huber point, spread the dural fibers apart rather than cutting them. The hole reseals more effectively afterward.

A meta-analysis comparing these two needle designs found that pencil-point needles resulted in substantially lower rates of post-dural-puncture headache and severe headache. Patients in the pencil-point group also needed epidural blood patches, the main treatment for persistent spinal headaches, far less often.¹⁰ The underlying logic is the same as in port access: a needle that parts fibers rather than coring them preserves the membrane’s integrity. The specific tip geometry differs between a Huber-point port needle and a Whitacre or Sprotte spinal needle, but the engineering philosophy is shared.

Reducing Friction With Advanced Coatings

One active area of development is making non-coring needles easier to insert. Because the tip geometry is less conventionally sharp than a standard bevel, pushing a Huber-point needle through skin and into a port septum requires more force. This contributes to patient discomfort and can make it harder for clinicians to feel the characteristic “pop” that signals the needle has seated in the reservoir. Researchers have experimented with plasma-polymerized coatings on needle surfaces to reduce friction. One study tested several coating compounds and found that one based on a silane-amine molecule reduced insertion forces by about 75% and extraction forces by about 50% compared to uncoated needles.¹¹ This technology is still in the research phase for widespread clinical adoption, but it points toward a future where port access could be significantly less painful and more precise.

Veterinary Applications

Implanted ports and non-coring needles are not limited to human medicine. Dogs undergoing long-term chemotherapy face the same problem human cancer patients do: repeated peripheral IV access damages veins, and caustic chemotherapy agents can cause severe tissue injury if they leak out of fragile vessels. A study placed totally implantable ports in 12 dogs with various tumors requiring extended chemotherapy protocols. The ports were accessed using non-coring needles the same way they would be in a human patient. The devices were well tolerated in most cases and could remain in place for several months, sparing peripheral veins from the damage of repeated vesicant drug infusions.¹² The concept translates directly across species because the engineering problem is the same: preserve the septum, protect the veins, deliver the drug reliably.

Common Misconceptions About Port Needles

A few misunderstandings circulate among patients and even occasionally among healthcare workers who do not routinely handle ports. One is that any needle can access a port in a pinch. As the case report of a silicone core occluding a port outlet demonstrated, using a standard hypodermic needle even once can compromise the device.³ Patients with ports should feel empowered to confirm that the needle being used is a non-coring type before any access.

Another misconception is that the needle is left in permanently. Non-coring needles are designed for temporary access, typically from minutes (a single blood draw or drug bolus) to a few days (continuous infusion). Leaving the needle in indefinitely increases infection risk and accelerates septum wear. Between treatments, the port sits entirely beneath the skin with no external hardware, which is one of its major advantages over other central line types.

A third confusion involves thinking that non-coring needles are painless because the septum, not nerve-rich tissue, is what they are designed to protect. The needle still passes through skin, subcutaneous tissue, and sometimes a bit of muscle to reach the port. The septum-preserving design benefits the device, not the patient’s nerve endings. Pain management during access is a separate concern, and effective options like topical lidocaine exist for patients who find the procedure uncomfortable.